4587 Investors following Natco Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Natco adds two product drugs to US sale pact
Natco Pharma Ltd. said on Friday it has added two injectible drugs for sale in the United States under an existing marketing tie-up with Akorn Inc, reports Reuters.
Natco Pharma Ltd . said on Friday it has added two injectible drugs for sale in the United States under an existing marketing tie-up with Akorn Inc, reports Reuters.
The drugs are used in the prevention of nausea and vomiting associated with chemotherapy.
With this, the total number of products sold under the tie-up had risen to four, including two other oncology products, the Indian company said in a statement.
Akorn also files abbreviated new drug applications for Natco's bulk drugs on a profit-sharing basis.
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Namma Metro | LIC Housing Finance | Tata Steel | Reliance Industries | Mahindra Satyam | Aurobindo Pharma | BSE Sensex | Montek Singh Ahluwalia | Vodafone Essar 
Akorn also files abbreviated new drug applications for Natco's bulk drugs on a profit-sharing basis.
